ArticlePloS one2022

Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.

Paolo Angelo Cortesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.